Revenue: The sum of all revenue fields included for a company's operating activities.
Ionis Pharmaceuticals, Inc. (IONS) had Revenue of $131.61M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$131.61M |
$-146.94M |
|
$1.46M |
|
$130.15M |
|
$278.47M |
|
$-146.86M |
|
$0.04M |
|
$-146.82M |
|
$-144.66M |
|
$-146.94M |
|
$-146.94M |
|
$-146.94M |
|
$-144.78M |
|
$-146.86M |
|
$-146.93M |
|
158.74M |
|
158.74M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$2.42B |
|
$102.92M |
|
$394.02M |
|
$2.81B |
|
$250.29M |
|
$1.25B |
|
$2.09B |
|
$2.34B |
|
$475.73M |
|
$475.73M |
|
$475.73M |
|
159.04M |
|
| Cash Flow Statement Financials | |
$-150.78M |
|
$170.46M |
|
$2.20M |
|
$242.08M |
|
$264.19M |
|
$22.11M |
|
$29.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.66 |
|
-- |
|
-- |
|
0.72 |
|
2.63 |
|
98.89% |
|
-111.59% |
|
-111.59% |
|
-- |
|
-111.56% |
|
-111.64% |
|
$-163.35M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.13 |
|
3.31 |
|
27.15 |
|
-30.89% |
|
-30.89% |
|
-5.22% |
|
-8.51% |
|
$2.99 |
|
$-1.03 |
|
$-0.95 |
|